Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Robert L. Truitt PhD

Robert L. Truitt PhD profile photo picture

Emeritus Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Pediatrics Hematology Oncology Blood and Marrow Transplant

View Curriculum Vitae

Research Experience

  • Adoptive Transfer
  • Alopecia
  • Biological Therapy
  • Bone Marrow Transplantation
  • Cell Separation
  • Cell Transplantation
  • Cord Blood Stem Cell Transplantation
  • Disease Models, Animal
  • Epidermis
  • Graft Rejection
  • Graft vs Host Reaction
  • Graft vs Leukemia Effect
  • Graft vs Tumor Effect
  • Hair
  • Hair Follicle
  • Hematopoietic Stem Cell Transplantation
  • Histocompatibility
  • Host vs Graft Reaction
  • Immune Tolerance
  • Immunity, Cellular
  • Immunocompromised Host
  • Immunologic Tests
  • Immunomagnetic Separation
  • Immunotherapy
  • Immunotherapy, Adoptive
  • Leukemia
  • Leukemia, Experimental
  • Monitoring, Immunologic
  • Neoplasms, Experimental
  • Peripheral Blood Stem Cell Transplantation
  • Radiation Chimera
  • Stem Cell Transplantation
  • T-Lymphocytes
  • Tissue Transplantation
  • Transplantation
  • Transplantation Chimera
  • Transplantation Conditioning
  • Transplantation Immunology
  • Transplantation Tolerance
  • Transplantation, Autologous
  • Transplantation, Heterologous

    • Methodologies and Techniques

  • Bone Marrow Transplantation
  • Flow Cytometry
  • Graft vs Leukemia Effect
  • Graft vs Tumor Effect
  • Hematopoietic Stem Cell Transplantation
  • Immunomagnetic Separation
  • Immunophenotyping
  • Transplantation Conditioning

    • Leadership Positions

  • Associate Director of Research Resources, MCW Cancer Center
  • Emeritus Professor of Pediatrics

    • Community Partnerships

  • Wisconsin Breast Cancer Showhouse for a Cure, Inc.
  • American Cancer Society
  • Midwest Athletes Against Childhood Cancer (MACC) Fund

    • Publications (79)

  • Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis. (Keever-Taylor CA, Browning MB, Johnson BD, Truitt RL, Bredeson CN, Behn B, Tsao A) Cytotherapy 2007;9(2):144-57 PMID: 17453966 SCOPUS ID: 2-s2.0-34047130792 04/25/2007       41 Citations
  • Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras. (Xia G, Truitt RL, Johnson BD) Biol Blood Marrow Transplant 2006 Apr;12(4):397-407 PMID: 16545723 SCOPUS ID: 2-s2.0-33644898608 03/21/2006       58 Citations
  • CD200, a "no danger" signal for hair follicles. (Rosenblum MD, Yancey KB, Olasz EB, Truitt RL) J Dermatol Sci 2006 Mar;41(3):165-74 PMID: 16386879 SCOPUS ID: 2-s2.0-32644461591 01/03/2006       69 Citations
  • Characterization of CD 200-receptor expression in the murine epidermis. (Rosenblum MD, Woodliff JE, Madsen NA, McOlash LJ, Keller MR, Truitt RL) J Invest Dermatol 2005 Dec;125(6):1130-8 PMID: 16354182 SCOPUS ID: 2-s2.0-32644457432 12/16/2005       26 Citations
  • Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host disease. (Xia G, Kovochich M, Truitt RL, Johnson BD) Biol Blood Marrow Transplant 2004 Nov;10(11):748-60 PMID: 15505606 SCOPUS ID: 2-s2.0-6444235650 10/27/2004       26 Citations
  • Expression of CD200 on epithelial cells of the murine hair follicle: a role in tissue-specific immune tolerance? (Rosenblum MD, Olasz EB, Yancey KB, Woodliff JE, Lazarova Z, Gerber KA, Truitt RL) J Invest Dermatol 2004 Nov;123(5):880-7 PMID: 15482475 SCOPUS ID: 2-s2.0-6344225337 10/16/2004       104 Citations
  • The Mortimer M. Bortin Lecture: to destroy by the reaction of immunity: the search for separation of graft-versus-leukemia and graft-versus-host. (Truitt RL) Biol Blood Marrow Transplant 2004 Aug;10(8):505-23 PMID: 15282529 SCOPUS ID: 2-s2.0-3543051151 07/30/2004       15 Citations
  • The T cell activation marker CD150 can be used to identify alloantigen-activated CD4(+)25+ regulatory T cells. (Browning MB, Woodliff JE, Konkol MC, Pati NT, Ghosh S, Truitt RL, Johnson BD) Cell Immunol 2004 Feb;227(2):129-39 PMID: 15135295 SCOPUS ID: 2-s2.0-2342634326 05/12/2004       18 Citations
  • CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance. (Rosenblum MD, Olasz E, Woodliff JE, Johnson BD, Konkol MC, Gerber KA, Orentas RJ, Sandford G, Truitt RL) Blood 2004 Apr 01;103(7):2691-8 PMID: 14644999 SCOPUS ID: 2-s2.0-1642414806 12/03/2003       73 Citations
  • CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. (Johnson BD, Konkol MC, Truitt RL) Biol Blood Marrow Transplant 2002;8(10):525-35 PMID: 12434947 SCOPUS ID: 2-s2.0-0036435911 11/19/2002       82 Citations
  • Characterization of a murine NKT cell tumor previously described as an acute myelogenous leukemia. (LaBelle JL, Truitt RL) Leuk Lymphoma 2002 Aug;43(8):1637-44 PMID: 12400607 SCOPUS ID: 2-s2.0-0036020969 10/29/2002       21 Citations
  • Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia. (LaBelle JL, Hanke CA, Blazar BR, Truitt RL) Blood 2002 Mar 15;99(6):2146-53 PMID: 11877291 SCOPUS ID: 2-s2.0-0037085792 03/06/2002       45 Citations
  • Donor natural killer (NK1.1+) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI. (Johnson BD, Dagher N, Stankowski WC, Hanke CA, Truitt RL) Biol Blood Marrow Transplant 2001;7(11):589-95 PMID: 11760146 SCOPUS ID: 2-s2.0-0035195863 01/05/2002       11 Citations
  • Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy. (Johnson BD, Becker EE, LaBelle JL, Truitt RL) J Immunol 1999 Dec 15;163(12):6479-87 PMID: 10586039 SCOPUS ID: 2-s2.0-0032741541 12/10/1999       63 Citations
  • Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation. (Truitt RL, Johnson BD, Hanke C, Talib S, Hearst JE) J Immunol 1999 Nov 01;163(9):5145-56 PMID: 10528221 SCOPUS ID: 2-s2.0-0032711448 10/21/1999       48 Citations
  • Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets. (Johnson BD, Becker EE, Truitt RL) Biol Blood Marrow Transplant 1999;5(3):123-32 PMID: 10392958 SCOPUS ID: 2-s2.0-0032616043 07/07/1999       54 Citations
  • Sca1(+)/Mac1(+) nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro. (Johnson BD, Hanke CA, Becker EE, Truitt RL) Cell Immunol 1998 Nov 01;189(2):149-59 PMID: 9790729 SCOPUS ID: 2-s2.0-0032211707 10/29/1998       12 Citations
  • Glycosphingolipids as novel targets for T-cell suppression by the B subunit of recombinant heat-labile enterotoxin. (Truitt RL, Hanke C, Radke J, Mueller R, Barbieri JT) Infect Immun 1998 Apr;66(4):1299-308 PMID: 9529046 PMCID: PMC108053 SCOPUS ID: 2-s2.0-0032036427 04/07/1998       35 Citations
  • Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon. (Flomenberg P, Piaskowski V, Truitt RL, Casper JT) J Virol 1996 Sep;70(9):6314-22 PMID: 8709259 PMCID: PMC190657 SCOPUS ID: 2-s2.0-0029793258 09/01/1996       51 Citations
  • The graft-versus-leukemia effect of post-transplant donor leukocyte infusion. (Johnson BD, Hanke CA, Truitt RL) Leuk Lymphoma 1996 Sep;23(1-2):1-9 PMID: 9021679 SCOPUS ID: 2-s2.0-0029803984 09/01/1996       13 Citations
  • Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. (Margolis D, Camitta B, Pietryga D, Keever-Taylor C, Baxter-Lowe LA, Pierce K, Kupst MJ, French J 3rd, Truitt R, Lawton C, Murray K, Garbrecht F, Flomenberg N, Casper J) Br J Haematol 1996 Jul;94(1):65-72 PMID: 8757510 SCOPUS ID: 2-s2.0-8944254249 07/01/1996       89 Citations
  • Hematologic and immunologic evaluation of recombinant human interleukin-6 in patients with advanced malignant disease: evidence for monocyte activation. (Keever-Taylor CA, Witt PL, Truitt RL, Ramanujam S, Borden EC, Ritch PS) J Immunother Emphasis Tumor Immunol 1996 May;19(3):231-43 PMID: 8811498 SCOPUS ID: 2-s2.0-0030018896 05/01/1996       19 Citations
  • Immunoregulatory properties of ISG15, an interferon-induced cytokine. (D'Cunha J, Knight E Jr, Haas AL, Truitt RL, Borden EC) Proc Natl Acad Sci U S A 1996 Jan 09;93(1):211-5 PMID: 8552607 PMCID: PMC40208 SCOPUS ID: 2-s2.0-0030051132 01/09/1996       342 Citations
  • Principles of graft-vs.-leukemia reactivity. (Truitt RL, Johnson BD) Biol Blood Marrow Transplant 1995 Dec;1(2):61-8 PMID: 9118293 SCOPUS ID: 2-s2.0-0029421456 12/01/1995       63 Citations
  • Phase IA/IB evaluation of mammalian cell-derived glycosylated recombinant human interleukin (SIGOSIX) before and after cytotoxic chemotherapy. (Ritch PS, Keever C, Schiller J, Rivkin S, Witt PL, Grossberg SE, Truitt RL, Burris H, von Hoff DD, Vaickus L) Ann N Y Acad Sci 1995 Jul 21;762:359-60 PMID: 7668536 SCOPUS ID: 2-s2.0-0029144651 07/21/1995    
  • Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease. (Johnson BD, Truitt RL) Blood 1995 Jun 01;85(11):3302-12 PMID: 7756664 SCOPUS ID: 2-s2.0-0029068065 06/01/1995       136 Citations
  • Use of anti-CD3 epsilon F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation. (Johnson BD, McCabe C, Hanke CA, Truitt RL) J Immunol 1995 May 15;154(10):5542-54 PMID: 7730653 SCOPUS ID: 2-s2.0-0028989604 05/15/1995       41 Citations
  • Characterization of human proliferative T cell responses to adenovirus. (Flomenberg P, Piaskowski V, Truitt RL, Casper JT) J Infect Dis 1995 May;171(5):1090-6 PMID: 7751682 SCOPUS ID: 2-s2.0-0028897676 05/01/1995       115 Citations
  • Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. (Casper J, Camitta B, Truitt R, Baxter-Lowe LA, Bunin N, Lawton C, Murray K, Hunter J, Pietryga D, Garbrecht F) Blood 1995 May 01;85(9):2354-63 PMID: 7727769 SCOPUS ID: 2-s2.0-0028921178 05/01/1995       133 Citations
  • Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. (Johnson BD, Drobyski WR, Truitt RL) Bone Marrow Transplant 1993 Apr;11(4):329-36 PMID: 8485480 SCOPUS ID: 2-s2.0-0027537527 04/01/1993       135 Citations
  • Detection of residual leukemia by the polymerase chain reaction and sequence-specific oligonucleotide probe hybridization after allogeneic bone marrow transplantation for AKR leukemia: a murine model for minimal residual disease. (Drobyski WR, Baxter-Lowe LA, Truitt RL) Blood 1993 Jan 15;81(2):551-9 PMID: 8422472 SCOPUS ID: 2-s2.0-0027534244 01/15/1993       11 Citations
  • A decrease in graft-vs.-host disease without loss of graft-vs.-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor NK cells in vivo. (Johnson BD, Truitt RL) Transplantation 1992 Jul;54(1):104-12 PMID: 1631918 SCOPUS ID: 2-s2.0-0026763856 07/01/1992       52 Citations
  • Immunological evaluation of pediatric cancer patients receiving recombinant interleukin-2 in a phase I trial. (Truitt RL, Piaskowski V, Kirchner P, McOlash L, Camitta BM, Casper JT) J Immunother (1991) 1992 May;11(4):274-85 PMID: 1599913 SCOPUS ID: 2-s2.0-0026550028 05/01/1992       19 Citations
  • Regulation of lymphokine-activated killer activity in T-replete and T-cell-depleted human bone marrow by interleukin 4. (Drobyski WR, LeFever AV, Truitt RL) Exp Hematol 1991 Oct;19(9):950-7 PMID: 1716592 SCOPUS ID: 2-s2.0-0025816631 10/01/1991       1 Citation
  • Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow. (Truitt RL, Atasoylu AA) Bone Marrow Transplant 1991 Jul;8(1):51-8 PMID: 1833016 SCOPUS ID: 2-s2.0-0025784907 07/01/1991       162 Citations
  • Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation. (Truitt RL, Atasoylu AA) Blood 1991 Jun 01;77(11):2515-23 PMID: 2039833 SCOPUS ID: 2-s2.0-0025819698 06/01/1991       109 Citations
  • Kinetic analysis of human IL-2 activated cytotoxic cells. (LeFever AV, Piaskowski VD, Casper JT, Truitt RL) Immunopharmacol Immunotoxicol 1991;13(1-2):147-68 PMID: 1770217 SCOPUS ID: 2-s2.0-0025767215 01/01/1991       4 Citations
  • Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow. (Drobyski WR, Piaskowski V, Ash RC, Casper JT, Truitt RL) Transplantation 1990 Oct;50(4):625-32 PMID: 1699309 SCOPUS ID: 2-s2.0-0025001706 10/01/1990       17 Citations
  • Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. (Ash RC, Casper JT, Chitambar CR, Hansen R, Bunin N, Truitt RL, Lawton C, Murray K, Hunter J, Baxter-Lowe LA) N Engl J Med 1990 Feb 22;322(8):485-94 PMID: 2300120 SCOPUS ID: 2-s2.0-11944271130 02/22/1990       263 Citations
  • Graft-versus-leukemia reactions after bone marrow transplantation. (Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringdén O, Rozman C, Speck B) Blood 1990 Feb 01;75(3):555-62 PMID: 2297567 SCOPUS ID: 2-s2.0-0025100777 02/01/1990       2579 Citations
  • Third-party-mediated graft rejection and graft-versus-host disease after T-cell-depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism. (Drobyski W, Thibodeau S, Truitt RL, Baxter-Lowe LA, Gorski J, Jenkins R, Gottschall J, Ash RC) Blood 1989 Nov 01;74(6):2285-94 PMID: 2572285 SCOPUS ID: 2-s2.0-0024448687 11/01/1989       77 Citations
  • T-cell depletion in allogeneic bone marrow transplantation: progress and problems. (Marmont AM, Gale RP, Butturini A, Goldman JM, Martelli MF, Prentice HG, Slavin S, Storb R, Truitt RL, Van Bekkum DW) Haematologica 1989;74(3):235-48 PMID: 2511092 SCOPUS ID: 2-s2.0-0024394032 05/01/1989       24 Citations
  • Serotonin modulated Ca++ dependent K+ channels in alloimmune effector cell lytic function. (Liepins A, LeFever A, Truitt RL) Immunopharmacol Immunotoxicol 1989;11(2-3):165-78 PMID: 2559929 SCOPUS ID: 2-s2.0-0024787724 01/01/1989       7 Citations
  • Role of K+ ion channels in lymphokine-activated killer (LAK) cell lytic function. (LeFever A, Liepins A, Truitt R) Immunopharmacol Immunotoxicol 1989;11(4):571-82 PMID: 2560785 SCOPUS ID: 2-s2.0-0024952019 01/01/1989       7 Citations
  • Partially matched bone marrow transplantation in patients with myelodysplastic syndromes. (Bunin NJ, Casper JT, Chitambar C, Hunter J, Truitt R, Menitove J, Camitta BM, Ash R) J Clin Oncol 1988 Dec;6(12):1851-5 PMID: 3058877 SCOPUS ID: 2-s2.0-0024270190 12/01/1988       38 Citations
  • Downregulation of L3T4+ cytotoxic T lymphocytes by interleukin-2. (Shih CC, Truitt RL) Science 1987 Oct 16;238(4825):344-7 PMID: 2443976 SCOPUS ID: 2-s2.0-0023231426 10/16/1987       11 Citations
  • Kinetic analysis of Qa-1-specific cloned cytotoxic T lymphocytes: lytic parameters and evaluation of cellular inhibition. (LeFever AV, Truitt RL) Scand J Immunol 1987 Jun;25(6):541-53 PMID: 2440099 SCOPUS ID: 2-s2.0-0023639124 06/01/1987       8 Citations
  • A class II antigen-specific T cell clone can suppress graft-versus-host reactivity in murine allogeneic bone marrow chimeras. (Shih CC, Truitt RL) Transplant Proc 1987 Feb;19(1 Pt 3):2664-7 PMID: 2950639 SCOPUS ID: 2-s2.0-0023295429 02/01/1987       2 Citations
  • Prophylaxis of graft-vs-host disease by adoptive transfer of a class II antigen-specific murine T-cell clone. (Shih CC, Truitt RL) Prog Clin Biol Res 1987;244:439-47 PMID: 3116558 SCOPUS ID: 2-s2.0-0023087693 01/01/1987       5 Citations
  • Migration of cytotoxic effector cells. (LeFever AV, Truitt RL) Prog Clin Biol Res 1987;244:313-24 PMID: 3498956 SCOPUS ID: 2-s2.0-0023084708 01/01/1987       4 Citations
  • Manipulation of T-cell content in transplanted human bone marrow: effect on GVH and GVL reactions. (Truitt RL, Ash RC) Prog Clin Biol Res 1987;244:409-21 PMID: 3310003 SCOPUS ID: 2-s2.0-0023074353 01/01/1987       16 Citations
  • Kinetic analysis of cloned cytotoxic T lymphocyte reactivity against normal and leukaemic target cells. (LeFever AV, Truitt RL) J Immunogenet 1986;13(2-3):275-85 PMID: 3493298 SCOPUS ID: 2-s2.0-0022895122 04/01/1986       14 Citations
  • Manipulation of graft-versus-host disease for a graft-versus-leukemia effect after allogeneic bone marrow transplantation in AKR mice with spontaneous leukemia/lymphoma. (Truitt RL, Shih CC, LeFever AV) Transplantation 1986 Mar;41(3):301-10 PMID: 3513389 SCOPUS ID: 2-s2.0-0022655109 03/01/1986       49 Citations
  • Reactivity of in-vitro-expanded alloimmune cytotoxic T lymphocytes and Qa-1-specific cytotoxic T lymphocytes against AKR leukemia in vivo. (LeFever AV, Truitt RL, Shih CC) Transplantation 1985 Nov;40(5):531-7 PMID: 2414869 SCOPUS ID: 2-s2.0-0022354572 11/01/1985       23 Citations
  • Isolation of suppressor-like T cells from bacteria-free allogeneic bone marrow chimeras. (Truitt RL, Shih CC) Prog Clin Biol Res 1985;181:451-4 PMID: 3161091 SCOPUS ID: 2-s2.0-0021936956 01/01/1985       1 Citation
  • Migration patterns and functional activity of cloned cytotoxic T lymphocytes in syngeneic and allogeneic mice. (LeFever AV, Truitt RL, Shih CC, Liepins A, Bortin MM) Transplantation 1984 Apr;37(4):410-7 PMID: 6200972 SCOPUS ID: 2-s2.0-0021253938 04/01/1984       13 Citations
  • Alloimmunization for induction of graft-versus-leukemia reactivity in H-2-compatible donors: critical role for incompatibility of donor and alloimmunizing strains at non-H-2 loci. (Bortin MM, Truitt RL, Shih CY, Tempelis LD, LeFever AV, Rimm AA) Transplant Proc 1983 Dec;15(4):2114-7 PMID: 6673211 SCOPUS ID: 2-s2.0-0021020734 12/01/1983       2 Citations
  • Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo. (Truitt RL, Shih CY, Lefever AV, Tempelis LD, Andreani M, Bortin MM) J Immunol 1983 Oct;131(4):2050-8 PMID: 6194224 SCOPUS ID: 2-s2.0-0020553787 10/01/1983       76 Citations
  • Growth of AKR T cell leukemia lymphoblasts in medium containing interleukin 2 (IL-2). (Shih CY, Truitt RL, Andreani M, Bortin MM) In Vitro 1983 Oct;19(10):759-66 PMID: 6605296 SCOPUS ID: 2-s2.0-0020980058 10/01/1983       9 Citations
  • Alloimmunization and adoptive immunotherapy of leukemia. (Truitt RL, Shih CY, Rimm AA, Tempelis LD, Bortin MM) Transplant Proc 1981 Dec;13(4):1910-4 PMID: 6949385 SCOPUS ID: 2-s2.0-0019831894 12/01/1981       1 Citation
  • Alloimmunization: induction of antileukemic reactivity without modification of anti-host reactivity in H-2-compatible mice. (Truitt RL, Bortin MM, Rimm AA) Transplant Proc 1980 Mar;12(1):143-6 PMID: 6966095 SCOPUS ID: 2-s2.0-0019223861 03/01/1980       3 Citations
  • Graft-versus-leukemia: allosensitization of MHC compatible donors induces antileukemic reactivity without amplification of antihost reactivity. (Bortin MM, Truitt RL, Shih CY, Rimm AA) Haematol Blood Transfus 1980;25:31-9 PMID: 7021349 SCOPUS ID: 2-s2.0-0019098657 01/01/1980       1 Citation
  • Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity. (Bortin MM, Truitt RL, Rimm AA, Bach FH) Nature 1979 Oct 11;281(5731):490-1 PMID: 386133 SCOPUS ID: 2-s2.0-0018697639 10/11/1979       137 Citations
  • Graft versus leukemia. VIII. Selective reduction in antihost reactivity without loss of antileukemic reactivity by treatment of donor mice with lipopolysaccharide. (Truitt RL, Rose WC, Rimm AA, Bortin MM) Exp Hematol 1978 May;6(5):488-98 PMID: 26584 SCOPUS ID: 2-s2.0-0017898443 05/01/1978       1 Citation
  • AKR T-cell acute lymphoblastic leukemia: a model for human T-cell leukemia. (Bortin-M, Truitt RL) Biomedicine 1977 Oct;26(5):309-11 PMID: 303119 SCOPUS ID: 2-s2.0-0017661736 10/01/1977       15 Citations
  • Growth of human tumors in lethally irradiated mice reconstituted with syngeneic fetal liver cells. (Saltzstein EC, Rose WC, Truitt RL, Rimm AA, Bortin MM, Patillo RA) Cancer 1977 Feb;39(2):581-6 PMID: 319894 SCOPUS ID: 2-s2.0-0017355308 02/01/1977    
  • Graft-versus-leukemia for AKR spontaneous leukemia-lymphoma. (Truitt RL, Rimm AA, Saltzstein EC, Rose WC, Bortin MM) Transplant Proc 1976 Dec;8(4):569-74 PMID: 11589 SCOPUS ID: 2-s2.0-0017040149 12/01/1976       7 Citations
  • Mouse leukemia and solid tumors treated with bone marrow grafting. (Pollard M, Truitt RL, Ashman RB) Transplant Proc 1976 Dec;8(4):565-7 PMID: 11588 SCOPUS ID: 2-s2.0-0017051785 12/01/1976       2 Citations
  • Transplantation of hematopoietic and lymphoid cells in mice. (Bortin MM, Rimm AA, Rose WC, Truitt RL, Saltzstein EC) Transplantation 1976 Apr;21(4):331-6 PMID: 7865 SCOPUS ID: 2-s2.0-0017235022 04/01/1976       6 Citations
  • Mitigation of graft-versus-host disease in mice by treatment of donors with bacterial endotoxin. (Rose WC, Rodey GE, Rimm AA, Truitt RL, Bortin MM) Exp Hematol 1976 Mar;4(2):90-6 PMID: 4335 SCOPUS ID: 2-s2.0-0017225652 03/01/1976       7 Citations
  • Adoptive immunotherapy of spontaneous leukemia-lymphoma in AKR mice. (Bortin MM, Truitt RL, Rose WC, Rimm AA, Saltzstein EC) Adv Exp Med Biol 1976;73 Pt B:331-9 PMID: 793340 SCOPUS ID: 2-s2.0-0017279108 01/01/1976       2 Citations
  • Allogeneic bone marrow chimerism in germ-free mice. IV. Therapy of "Hodgkin's-like" reticulum cell sarcoma in SJL mice. (Truitt RL, Pollard M) Transplantation 1976 Jan;21(1):12-6 PMID: 1108322 SCOPUS ID: 2-s2.0-0017293903 01/01/1976       18 Citations
  • Graft versus leukemia. VI. Adoptive immunotherapy in combination with chemoradiotherapy for spontaneous leukemia-lymphoma in AKR mice. (Bortin MM, Rose WC, Truitt RL, Rimm AA, Saltzstein EC, Rodey GE) J Natl Cancer Inst 1975 Nov;55(5):1227-9 PMID: 1546 SCOPUS ID: 2-s2.0-0016702434 11/01/1975       6 Citations
  • Low-dose chemotherapy as a prelude to intensive treatment of spontaneous leukemia-lymphoma in AKR mice. (Rose WC, Rimm AA, Saltzstein EC, Truitt RL, Bortin MM) J Natl Cancer Inst 1975 Jul;55(1):219-21 PMID: 1159816 SCOPUS ID: 2-s2.0-0016751512 07/01/1975       3 Citations
  • Allogeneic bone marrow chimerism in germfree mice. 3. Therapy of leukemic AKR mice. (Truitt RL, Pollard M, Srivastava KK) Proc Soc Exp Biol Med 1974 May;146(1):153-8 PMID: 4597165 SCOPUS ID: 2-s2.0-0016256702 05/01/1974       19 Citations
  • Allogeneic bone marrow chimerism in germ-free mice. II. Prevention of reticulum cell sarcomas in SJL-J mice. (Pollard M, Truitt RL) Proc Soc Exp Biol Med 1974 Feb;145(2):488-92 PMID: 4592169 SCOPUS ID: 2-s2.0-0015951195 02/01/1974       12 Citations
  • Allogeneic bone marrow chimerism in germfree mice. 1. Prevention of spontaneous leukemia in AKR mice. (Pollard M, Truitt RL) Proc Soc Exp Biol Med 1973 Nov;144(2):659-65 PMID: 4583624 SCOPUS ID: 2-s2.0-0015896583 11/01/1973       24 Citations
  • The replication of bovine viral diarrhea-mucosal disease virus in bovine leukocytes in vitro. (Truitt RL, Schechmeister IL) Arch Gesamte Virusforsch 1973;42(1):78-87 PMID: 4749260 SCOPUS ID: 2-s2.0-34250430804 01/01/1973       20 Citations
  • Ultrastructural examination of phytohemagglutinin stimulated lymphocytes infected with vesicular stomatitis virus. (McFadden GK, Truitt RL, Shechmeister IL) Arch Gesamte Virusforsch 1973;41(3):229-37 PMID: 4353796 SCOPUS ID: 2-s2.0-34250436331 01/01/1973    
    • Last update: 10/30/2012